Posted on August 25, 2017 by Sitemaster
The results of two recent, large clinical trials may have some impact on the clinical use of cabazitaxel (Jevtana) in the treatment of late-stage prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: cabazitaxel, docetaxel, dosing, Jevtana, outcome, Taxotere | 3 Comments »
Posted on January 15, 2013 by Sitemaster
A few days ago we reported on a paper by a Finnish research team who had compared treatment of men with mCRPC with docetaxel given every 2 weeks as opposed to the standard therapy of every 3 weeks. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: castration-resistant, docetaxel, dosing, frequency, mCRPC, metastatic | Leave a comment »
Posted on April 26, 2009 by Sitemaster
The following four reports address some other interesting papers and posters presented at the AUA today. … READ MORE …
Filed under: Management, Treatment | Tagged: active surveillance, dosing, Epsetins's criteria, Gleason score, LHRH therapy, positive surgical margins | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 